A Study to Determine the Effectiveness of Utilizing Intraperitoneal Bupivacaine

NCT03004222 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 137

Last updated 2018-01-18

No results posted yet for this study

Summary

The purpose of this research is to determine if spraying a local anesthetic to the cecum after a laparoscopic appendectomy decreases the amount of narcotics (pain medicine) needed after surgery and reduces the time to discharge from the hospital.

Conditions

  • Laparoscopic Appendectomy

Interventions

DRUG

Bupivacaine

20 ml of 0.5% Bupivacaine

DRUG

Placebos

Sponsors & Collaborators

  • Metro Health, Michigan

    lead OTHER

Principal Investigators

  • Karlin Sevensma, DO · Metro Health Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-07-31
Primary Completion
2017-11-30
Completion
2017-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03004222 on ClinicalTrials.gov